Evidence map›Paper›PMID 38870437›Full record

ArticleJCO global oncology2024

Multinational, Multicenter Evaluation of Prostate Cancer Tissue in Sub-Saharan Africa: Challenges and Opportunities.

Abraham C van Wyk, Priti Lal, J Olufemi Ogunbiyi, Lynnette Kyokunda, Fred Hobenu, Cherif Dial, Mohamed Jalloh, Richard Gyasi, Olabode P Oluwole, Afua D Abrahams and 21 more

Abstract readMulticenter Study
In one paragraph

Article in JCO global oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors.

Abraham C van WykStellenbosch University and National Health Laboratory Service, Tygerberg Hospital, Cape Town, South Africa.ORCID 0000-0002-0946-2434
Priti LalUniversity of Pennsylvania, Philadelphia, PA.ORCID 0000-0002-7308-0190
J Olufemi OgunbiyiUniversity College Hospital/University of Ibadan, Ibadan, Nigeria.ORCID 0000-0002-8748-2879
Lynnette KyokundaUniversity of Botswana, Gaborone, Botswana.
Fred Hobenu37 Military Hospital, Accra, Ghana.
Cherif DialHôpital Général Idrissa Pouye, Dakar, Sénégal.
Mohamed JallohHôpital Général Idrissa Pouye, Dakar, Sénégal.
Richard GyasiKorle-Bu Teaching Hospital, Accra, Ghana.
Olabode P OluwoleUniversity of Abuja, Abuja, Nigeria.
Afua D AbrahamsKorle-Bu Teaching Hospital, Accra, Ghana.ORCID 0000-0003-0649-3996
Adam R BothaDepartment of Anatomical Pathology, Faculty of Health Sciences, University of the Witwatersrand and the National Health Laboratory Service, Johannesburg, South Africa.ORCID 0000-0002-7083-7602
Nompumelelo Zamokuhle MtshaliDepartment of Anatomical Pathology, Faculty of Health Sciences, University of the Witwatersrand and the National Health Laboratory Service, Johannesburg, South Africa.ORCID 0000-0001-5971-6853
Caroline AndrewsDana-Farber Cancer Institute, Boston, MA.ORCID 0000-0001-5818-4365
Sunny Mante37 Military Hospital, Accra, Ghana.ORCID 0000-0002-8952-8594
Ben Adusei37 Military Hospital, Accra, Ghana.
Serigne M GueyeHôpital Général Idrissa Pouye, Dakar, Sénégal.
James E MensahKorle-Bu Teaching Hospital, Accra, Ghana.ORCID 0000-0003-4133-1722
Andrew Anthony AdjeiKorle-Bu Teaching Hospital, Accra, Ghana.
Yao TetteyKorle-Bu Teaching Hospital, Accra, Ghana.ORCID 0000-0002-7004-8806
Akin AdebiyiUniversity College Hospital/University of Ibadan, Ibadan, Nigeria.
Oseremen Aisuodionoe-ShadrachUniversity of Abuja, Abuja, Nigeria.
Sefiu Bolarinwa EniolaUniversity of Abuja, Abuja, Nigeria.
Amparo SernaMoffitt Cancer Center & Research Institute, Tampa, FL.
Kosj YamoahMoffitt Cancer Center & Research Institute, Tampa, FL.ORCID 0000-0001-9055-3538
Wenlong Carl ChenNational Cancer Registry, National Institute for Communicable Diseases a Division of the National Health Laboratory Service, Johannesburg, South Africa.ORCID 0000-0002-3248-4906
Pedro FernandezDivision of Urology, Department of Surgical Sciences, Stellenbosch University, Cape Town, South Africa.ORCID 0000-0002-8728-9032
Brian D RobinsonWeill Cornell Medical Center, New York, NY.ORCID 0000-0001-5374-890X
Juan Miguel MosqueraWeill Cornell Medical Center, New York, NY.ORCID 0000-0003-4666-6476
Ann W HsingStanford Cancer Institute, Stanford School of Medicine, Palo Alto, CA.
Ilir AgalliuAlbert Einstein College of Medicine, New York, NY.ORCID 0000-0002-6248-5790
Timothy R RebbeckDepartment of Anatomical Pathology, Faculty of Health Sciences, University of the Witwatersrand and the National Health Laboratory Service, Johannesburg, South Africa.ORCID 0000-0002-4799-1900

Funding

Nutritional Assessment of Cancer Risk in African MenU01CA184374 · NCI · DANA-FARBER CANCER INST · PI REBBECK, TIMOTHY R · 2015 to 2019
$9.1M
Genomic Diversity of Prostate Cancer Across the African DiasporaR01CA259200 · NCI · DANA-FARBER CANCER INST · PI TIMOTHY RICHARD REBBECK · 2022 to 2026
$6.4M
NCI NIH HHS R01 CA259200NCI NIH HHS U01 CA184374
6 · The paper itself

Abstract

purposeProstate cancer disproportionately affects men of African descent, yet their representation in tissue-based studies is limited. This multinational, multicenter pilot study aims to establish the groundwork for collaborative research on prostate cancer in sub-Saharan Africa.

methodsThe Men of African Descent and Carcinoma of the Prostate network formed a pathologist working group representing eight institutions in five African countries. Formalin-fixed paraffin-embedded prostate tissue specimens were collected from Senegal, Nigeria, and Ghana. Histology slides were produced and digitally scanned. A central genitourinary pathologist (P.L.) and eight African general pathologists reviewed anonymized digital whole-slide images for International Society of Urological Pathology grade groups and other pathologic parameters. Discrepancies were re-evaluated, and consensus grading was assigned. A virtual training seminar on prostate cancer grading was followed by a second assessment on a subcohort of the same tissue set.

resultsOf 134 tissue blocks, 133 had evaluable tissue; 13 lacked cancer evidence, and four were of insufficient quality. Post-training, interobserver agreement for grade groups improved to 56%, with a median Cohen's quadratic weighted kappa of 0.83 (mean, 0.74), compared with an initial 46% agreement and a quadratic weighted kappa of 0.77. Interobserver agreement between African pathologist groups was 40%, with a quadratic weighted kappa of 0.66 (95% CI, 0.51 to 0.76). African pathologists tended to overgrade (36%) more frequently than undergrade (18%) compared with the reference genitourinary pathologist. Interobserver variability tended to worsen with a decrease in tissue quality.

conclusionTissue-based studies on prostate cancer in men of African descent are essential for a better understanding of this common disease. Standardized tissue handling protocols are crucial to ensure good tissue quality and data. The use of digital slide imaging can enhance collaboration among pathologists in multinational, multicenter studies.

Indexed as

Prostatic NeoplasmsAfrica South of the SaharaHumansMaleNeoplasm GradingPilot Projects

Identifiers

PMID38870437
PMCPMC11191871

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.